The three Sopharma AD factories - the one in Kazanlak, the Tablet production and Ampoule...
Business & Markets
The state-of-the-art solid dosage forms manufacturing facility of Sopharma AD in Sofia.
Jump to navigation
The Board of Directors of Sopharma AD adheres to the Good Corporate Governance Program, which is in line with the effective regulation, the internationally recognized good corporate governance standards and the Bulgarian National Corporate Governance Code.
The PRINCIPLES on which the Program framework is based are:
The Program is updated timely when a change in circumstances or in corporate strategy occurs.
The AIMS of the Program are
Sopharma periodically discloses information about corporate governance in accordance with the "comply or explain" principle. In the event of non-compliance with the recommendations of the Code we provide an explanation.
On 3 September 2009 Mr. Ognian Donev, Executive Director of Sopharma AD, was elected member of the newly established Bulgarian National Committee on Corporate Governance.
It was established under the auspices of the Financial Supervision Commission and the Bulgarian Stock Exchange, with support from the World Bank and the International Finance Corporation (IFC) and aims to continually monitor compliance by companies of the National Code of Corporate Governance.
The Commission will also propose changes to the relevant legislation in the Code itself.